Avadel to Unveil New Data on Lumryz for Narcolepsy Treatment
Avadel Pharmaceuticals will present new data supporting the clinical profile for Lumryz for narcolepsy in 12 abstracts at SLEEP 2023.
Source: sleepreviewmag.com
Stay updated with breaking news from New Narcolepsy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avadel Pharmaceuticals will present new data supporting the clinical profile for Lumryz for narcolepsy in 12 abstracts at SLEEP 2023.
– 12 accepted abstracts highlight Company’s emerging leadership in narcolepsy – – Data adds to growing body of evidence demonstrating positive clinical benefit and patient... | June 10, 2023